News & Blog

5 January 2022
Pathfinder’s venture building team expands Marek Friedman, a C-level executive with over 20 years experience in managing companies operating in media and e-commerce sectors, among others, has joined the fund’s team as an Interim CEO of its portfolio companies.
24 November 2021
Jan Brandes joins Tar Heel Capital Pathfinder as advisor Jan Brandes, a corporate finance expert, joins Pathfinder’s team to leverage his over 16’ years experience in advising leading European tech companies and investors for the benefit of the startups from our portfolio.
9 November 2021
RemoteMyApp moves to the next level: Polish tech startup acquired by international corporation RemoteMyApp, a Szczecin-based startup providing technology and services for streaming games from the cloud to international corporations, will itself become the property of a global player: the company has been acquired by Intel Corporation.
27 October 2021
Zalando – brainchild of venture building The global market of organisations operating in the venture building model is in its heyday. Among entrepreneurs, however, there is still a lot of doubt about what venture building really is. Learn more about its advantages, how it differs from the support received from incubators, and how it can be used by startups essentially looking for the typical venture capital financing.
16 September 2021
A strong debut of Woodpecker on NewConnect Another company from the portfolio of Tar Heel Capital Pathfinder has begun its journey in the capital markets. made its debut on the alternative market of the Warsaw Stock Exchange. The company is already planning the next step: transitioning to the main stock exchange.
24 August 2021
NaturalAntibody: Oxford scientist joins forces with Tar Heel Capital Pathfinder to revolutionise the process of drug manufacturing Tar Heel Capital Pathfinder is investing in the revolution in the pharma industry. The fund joined forces with the world-class expert in the field of bioinformatic antibody analysis, Dr. Konrad Krawczyk. Together, they created NaturalAntibody, a company offering bioinformatic solutions that allow to significantly reduce the costs and accelerate the process of bringing antibody-based drugs to the market. The company’s products are already used by AstraZeneca, among others.
16 August 2021
Unikrn to be acquired by the betting and gaming giant, Entain Entain, one of the world’s largest sports betting and gaming businesses, has announced its acquisition of Unikrn, a leading esports betting and entertainment media company and a portfolio company of Tar Heel Capital Pathfinder.
24 June 2021
Pathfinder invests in Portside Portside is an e-commerce platform offering customers from the whole of Poland access to fish and seafood sourced from the best ports in Europe. Tar Heel Capital Pathfinder invested PLN 1 million in the company